Hepatitis b vaccine pregnancy registry pulled before enrolling a single participant
NCT ID NCT06097312
First seen May 19, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study was designed to monitor the safety of the PREHEVBRIO hepatitis B vaccine in pregnant women by collecting data on pregnancy and baby outcomes. It planned to enroll women who received the vaccine shortly before or during pregnancy. However, the registry was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINE EXPOSURE DURING PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ProPharma, Recruiting Nationwide
Overland Park, Kansas, 66210, United States
Conditions
Explore the condition pages connected to this study.